These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5806868)

  • 1. Nardil response in a chronic obsessive compulsive.
    Annesley PT
    Br J Psychiatry; 1969 Jun; 115(523):748. PubMed ID: 5806868
    [No Abstract]   [Full Text] [Related]  

  • 2. A remarkable response of chronic severe obsessive-compulsive neurosis to phenelzine.
    Mahgoub OM
    Acta Psychiatr Scand; 1987 Feb; 75(2):222-3. PubMed ID: 3565070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J; Olivares J; Marcos T; Bulbena A; Menchón JM
    Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of phenelzine and imipramine in an obsessive-compulsive patient.
    Isberg RS
    Am J Psychiatry; 1981 Sep; 138(9):1250-1. PubMed ID: 7270738
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of the phobic obsessive-compulsive patient with oxazepam, an improved benzodiazepine compound.
    Orvin GH
    Psychosomatics; 1967; 8(5):278-80. PubMed ID: 4862919
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenelzine in obsessional neurosis.
    Jain VK; Swinson RP; Thomas JG
    Br J Psychiatry; 1970 Aug; 117(537):237-8. PubMed ID: 5480680
    [No Abstract]   [Full Text] [Related]  

  • 8. An integrated approach to treatment of obsessive compulsive disorder.
    Greist JH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combined antidepressant therapy in resistant neurotic disorder.
    Tyrer P; Murphy S
    Br J Psychiatry; 1990 Jan; 156():115-8. PubMed ID: 2404536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization.
    Koran LM; Leventhal JL; Fireman B; Jacobson A
    Am J Health Syst Pharm; 2000 Nov; 57(21):1972-8. PubMed ID: 11094651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of obsessive-compulsive neurosis.
    Hussain MZ; Ahad A
    Can Med Assoc J; 1970 Sep; 103(6):648 passim. PubMed ID: 5455288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of clinical trial of Ro-4-6270 in depressive-anxiety states].
    Ardito R; Paterni F
    Riv Neurobiol; 1967; 13(1):3-10. PubMed ID: 5602736
    [No Abstract]   [Full Text] [Related]  

  • 14. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder.
    Gentil AF; Lopes AC; Dougherty DD; Rück C; Mataix-Cols D; Lukacs TL; Canteras MM; Eskandar EN; Larsson KJ; Hoexter MQ; Batistuzzo MC; Greenberg BD; Miguel EC
    J Neurosurg; 2014 Jul; 121(1):123-30. PubMed ID: 24702323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of leukopenia associated with phenelzine.
    Tipermas A; Gilman HE; Russakoff LM
    Am J Psychiatry; 1984 Jun; 141(6):806-7. PubMed ID: 6731626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of riluzole augmentation in a patient with treatment-resistant obsessive-compulsive disorder, taking two other glutaminergic agents.
    Mahgoub N; Asemota B; Alexopoulos GS
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E24-5. PubMed ID: 21677213
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
    Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
    Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of a new drug, analog of chlordiazepoxide, for treatment of anxiety and tension.
    Gilbert MM
    Int J Neuropsychiatry; 1965 Dec; 1(6):556-8. PubMed ID: 5886535
    [No Abstract]   [Full Text] [Related]  

  • 20. Buspirone in obsessional compulsive disorder. A prospective case study.
    Farid BT; Bulto M
    Pharmacopsychiatry; 1994 Sep; 27(5):207-9. PubMed ID: 7838892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.